NeuroPace, Inc.
NASDAQ:NPCE
9.73 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 23.52 | 22.524 | 21.466 | 21.06 | 19.256 | 18.124 | 18.012 | 16.427 | 16.51 | 14.472 | 12.789 | 11.157 | 10.2 | 11.374 | 10.997 | 10.339 | 12.63 | 11.217 | 10.752 | 12.771 | 7.64 | 9.975 |
| Cost of Revenue
| 5.388 | 5.182 | 5.278 | 5.64 | 5.122 | 4.781 | 4.467 | 4.194 | 4.538 | 4.1 | 3.986 | 3.192 | 2.734 | 3.115 | 2.921 | 2.832 | 3.271 | 2.724 | 2.533 | 3.196 | 2.219 | 2.918 |
| Gross Profit
| 18.132 | 17.342 | 16.188 | 15.42 | 14.134 | 13.343 | 13.545 | 12.233 | 11.972 | 10.372 | 8.803 | 7.965 | 7.466 | 8.259 | 8.076 | 7.507 | 9.359 | 8.493 | 8.219 | 9.575 | 5.421 | 7.057 |
| Gross Profit Ratio
| 0.771 | 0.77 | 0.754 | 0.732 | 0.734 | 0.736 | 0.752 | 0.745 | 0.725 | 0.717 | 0.688 | 0.714 | 0.732 | 0.726 | 0.734 | 0.726 | 0.741 | 0.757 | 0.764 | 0.75 | 0.71 | 0.707 |
| Reseach & Development Expenses
| 6.845 | 7.44 | 6.05 | 5.754 | 6.065 | 5.784 | 5.377 | 4.795 | 5.343 | 5.263 | 5.089 | 5.611 | 5.669 | 5.577 | 5.345 | 4.329 | 4.437 | 4.1 | 3.919 | 3.691 | 3.252 | 4.833 |
| General & Administrative Expenses
| 6.068 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 12.043 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 18.111 | 15.049 | 13.791 | 13.909 | 14.299 | 15.104 | 13.219 | 13.388 | 14.483 | 13.428 | 13.573 | 12.553 | 12.771 | 12.444 | 11.746 | 9.421 | 9.527 | 8.267 | 7.281 | 7.05 | 5.615 | 7.682 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.122 | 0 | -0.146 | -0.103 | -0.085 | -0.003 | 0 | -0.014 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 24.956 | 22.489 | 19.841 | 19.663 | 20.364 | 20.888 | 18.596 | 18.183 | 19.826 | 18.691 | 18.662 | 18.164 | 18.44 | 18.021 | 17.091 | 13.75 | 13.964 | 12.367 | 11.2 | 10.741 | 8.867 | 12.515 |
| Operating Income
| -6.824 | -5.147 | -3.653 | -4.243 | -6.23 | -7.545 | -5.051 | -5.95 | -7.854 | -8.319 | -9.859 | -10.199 | -10.974 | -9.762 | -9.015 | -6.243 | -4.605 | -3.874 | -2.981 | -1.166 | -3.446 | -5.458 |
| Operating Income Ratio
| -0.29 | -0.229 | -0.17 | -0.201 | -0.324 | -0.416 | -0.28 | -0.362 | -0.476 | -0.575 | -0.771 | -0.914 | -1.076 | -0.858 | -0.82 | -0.604 | -0.365 | -0.345 | -0.277 | -0.091 | -0.451 | -0.547 |
| Total Other Income Expenses Net
| -1.827 | -1.442 | -1.597 | -1.209 | -1.284 | -1.38 | -1.149 | -1.307 | -1.27 | -2.056 | -1.287 | -1.586 | -1.716 | -1.699 | -1.678 | -1.84 | -3.889 | -4.936 | -1.637 | -2.96 | -5.347 | -1.283 |
| Income Before Tax
| -8.651 | -6.589 | -5.25 | -5.452 | -7.514 | -8.925 | -6.2 | -7.257 | -9.124 | -10.375 | -11.146 | -11.785 | -12.69 | -11.461 | -10.693 | -8.083 | -8.494 | -8.81 | -4.618 | -4.126 | -8.793 | -6.741 |
| Income Before Tax Ratio
| -0.368 | -0.293 | -0.245 | -0.259 | -0.39 | -0.492 | -0.344 | -0.442 | -0.553 | -0.717 | -0.872 | -1.056 | -1.244 | -1.008 | -0.972 | -0.782 | -0.673 | -0.785 | -0.43 | -0.323 | -1.151 | -0.676 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.021 | 1.287 | 1.586 | 1.716 | 1.699 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| 0 | -6.589 | -5.25 | -5.452 | -7.514 | -8.925 | -6.2 | -7.257 | -9.124 | -14.396 | -12.433 | -13.371 | -14.406 | -13.16 | -10.693 | -8.083 | -8.494 | -8.81 | -4.618 | -4.126 | -8.793 | -6.741 |
| Net Income Ratio
| 0 | -0.293 | -0.245 | -0.259 | -0.39 | -0.492 | -0.344 | -0.442 | -0.553 | -0.995 | -0.972 | -1.198 | -1.412 | -1.157 | -0.972 | -0.782 | -0.673 | -0.785 | -0.43 | -0.323 | -1.151 | -0.676 |
| EPS
| -0.26 | -0.21 | -0.18 | -0.19 | -0.26 | -0.32 | -0.23 | -0.28 | -0.36 | -0.57 | -0.5 | -0.54 | -0.59 | -0.54 | -0.44 | -0.34 | -0.48 | -0.4 | -0.42 | -0.37 | -0.79 | -0.61 |
| EPS Diluted
| -0.26 | -0.21 | -0.18 | -0.19 | -0.26 | -0.32 | -0.23 | -0.28 | -0.36 | -0.57 | -0.5 | -0.54 | -0.59 | -0.54 | -0.44 | -0.34 | -0.48 | -0.4 | -0.42 | -0.37 | -0.79 | -0.61 |
| EBITDA
| -6.824 | -3.974 | -2.607 | -2.819 | -4.904 | -6.244 | -3.555 | -4.668 | -6.596 | -8.015 | -8.453 | -9.14 | -10.094 | -8.879 | -8.752 | -6.157 | -6.553 | -6.887 | -2.664 | -1.234 | -4.898 | -3.661 |
| EBITDA Ratio
| -0.29 | -0.176 | -0.121 | -0.134 | -0.255 | -0.345 | -0.197 | -0.284 | -0.4 | -0.554 | -0.661 | -0.819 | -0.99 | -0.781 | -0.796 | -0.596 | -0.519 | -0.614 | -0.248 | -0.097 | -0.641 | -0.367 |